These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6878294)

  • 1. The Clinical Oncology Program (COP) model for cancer control: breast cancer.
    Dugan WM; Woods JR; Minnick DJ
    Prog Clin Biol Res; 1983; 120():347-59. PubMed ID: 6878294
    [No Abstract]   [Full Text] [Related]  

  • 2. Community Hospitals Indianapolis creates breast cancer awareness. The hospital joins a partnership with local ABC affiliate.
    Herreria J
    Profiles Healthc Mark; 1999; 15(2):24-7, 3. PubMed ID: 10387298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
    Klabunde C; Kaluzny A; Ford L
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the effectiveness of the professional education component of a comprehensive cancer control project using serial "patterns of care" (POC) studies.
    Vaughan WP; Morlock LL; Lenhard RE; Rausch GP; Watkins SP; Kane JM; Waalkes TP
    Prog Clin Biol Res; 1983; 130():425-32. PubMed ID: 6622477
    [No Abstract]   [Full Text] [Related]  

  • 5. A national cancer control program: the 'Down Under' experience with breast cancer.
    Luxford K; Zorbas H
    Cancer Causes Control; 2009 Feb; 20(1):105-14. PubMed ID: 18791801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data feedback and structured group judgement methods in the development of breast cancer management guidelines in community hospitals.
    Finison LJ; Williamson JW; Patterson WB; Braun J; Jacques P; Knab R
    Prog Clin Biol Res; 1983; 120():327-35. PubMed ID: 6878292
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer control through a network of community hospitals.
    Engstrom PF
    Prog Clin Biol Res; 1983; 120():237-46. PubMed ID: 6878283
    [No Abstract]   [Full Text] [Related]  

  • 8. Recruitment of underserved women for breast cancer detection programs.
    Zabora JR; Morrison C; Olsen SJ; Ashley B
    Cancer Pract; 1997; 5(5):297-303. PubMed ID: 9341352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of health care services provided to women enrolled in a community-based breast and cervical cancer screening program.
    Burack R; Latafa J
    J Health Care Poor Underserved; 2009 Aug; 20(3):713-20. PubMed ID: 19648699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community cancer control of Los Angeles (CCC/LA): breast examination training (BET) centers.
    Lee C
    Prog Clin Biol Res; 1983; 130():283-92. PubMed ID: 6622460
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.
    McCann SE; Kulkarni S; Trevisan M; Vito D; Nie J; Edge SB; Muti P; Freudenheim JL
    Breast Cancer Res Treat; 2006 Oct; 99(3):309-11. PubMed ID: 16541305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizations and structures that facilitate community research.
    Coltman CA
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):107-11. PubMed ID: 8091235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
    Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
    Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.
    Kumar AS; Campbell M; Benz CC; Esserman LJ
    J Clin Oncol; 2006 May; 24(13):2127; author reply 2127-8. PubMed ID: 16648516
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening clinical breast examination: how often does it miss lethal breast cancer?
    Fenton JJ; Barton MB; Geiger AM; Herrinton LJ; Rolnick SJ; Harris EL; Barlow WE; Reisch LM; Fletcher SW; Elmore JG
    J Natl Cancer Inst Monogr; 2005; (35):67-71. PubMed ID: 16287888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What providers should know about community cancer control.
    Friedell GH; Linville LH; Rubio A; Wagner WD; Tucker TC
    Cancer Pract; 1997; 5(6):367-74. PubMed ID: 9397705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Going the extra mile in patient care. An innovative program helps breast cancer patients navigate the healthcare system.
    Foy JE
    Healthc Exec; 2002; 17(6):66-7. PubMed ID: 12416349
    [No Abstract]   [Full Text] [Related]  

  • 18. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing cancer outcome: the role of LSUMC Minority-Based Clinical Community Oncology Program.
    Hayden J; Veith R; Thomas SM; Austin JP; Moore T
    J La State Med Soc; 1997 Apr; 149(4):131-3. PubMed ID: 9130816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Por La Vida intervention model for cancer prevention in Latinas.
    Navarro AM; Senn KL; Kaplan RM; McNicholas L; Campo MC; Roppe B
    J Natl Cancer Inst Monogr; 1995; (18):137-45. PubMed ID: 8562214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.